Allergan Stock Price, News & Analysis (NYSE:AGN)

Allergan trades on the New York Stock Exchange (NYSE) under the ticker symbol "AGN."

Allergan announced a quarterly dividend on Friday, July 19th. Stockholders of record on Tuesday, August 13th will be paid a dividend of $0.74 per share on Friday, September 13th. This represents a $2.96 annualized dividend and a dividend yield of 1.78%. The ex-dividend date of this dividend is Monday, August 12th. View Allergan's Dividend History.

Allergan announced that its board has approved a share buyback program on Tuesday, January 29th 2019, which allows the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy up to 4.1% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's leadership believes its shares are undervalued.

Allergan plc (NYSE:AGN) released its quarterly earnings data on Tuesday, August, 6th. The company reported $4.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.34 by $0.04. The firm earned $4.09 billion during the quarter, compared to the consensus estimate of $3.93 billion. Allergan had a positive return on equity of 8.73% and a negative net margin of 54.25%. The firm's revenue for the quarter was down .8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $4.42 EPS. View Allergan's Earnings History.

Allergan is scheduled to release their next quarterly earnings announcement on Tuesday, October 29th 2019. View Earnings Estimates for Allergan.

Allergan issued an update on its FY19 earnings guidance on Tuesday, August, 6th. The company provided earnings per share guidance of >$16.55 for the period, compared to the Thomson Reuters consensus estimate of $16.74. The company issued revenue guidance of 15.4-15.6 billion, compared to the consensus revenue estimate of $15.32 billion.

21 brokerages have issued 12 month target prices for Allergan's stock. Their predictions range from $144.95 to $255.00. On average, they expect Allergan's share price to reach $178.7515 in the next year. This suggests a possible upside of 7.4% from the stock's current price. View Analyst Price Targets for Allergan.

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allergan in the last year. There are currently 15 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Allergan.

News headlines about AGN stock have been trending somewhat negative on Sunday, according to InfoTrie Sentiment. The research firm identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Allergan earned a daily sentiment score of -1.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Allergan.

Allergan saw a increase in short interest in August. As of August 31st, there was short interest totalling 7,261,500 shares, an increase of 22.5% from the July 31st total of 5,926,900 shares. Based on an average daily volume of 4,930,000 shares, the short-interest ratio is currently 1.5 days. Approximately 2.2% of the shares of the stock are sold short. View Allergan's Current Options Chain.

Some companies that are related to Allergan include Merck & Co., Inc. (MRK), Pfizer (PFE), Novartis (NVS), Abbott Laboratories (ABT), Novo Nordisk A/S (NVO), AstraZeneca (AZN), Sanofi (SNY), Eli Lilly And Co (LLY), AbbVie (ABBV), GlaxoSmithKline (GSK), Bristol-Myers Squibb (BMY), Commonwealth Bank of Australia (CSLLY), Celgene (CELG), Bayer (BAYRY) and Zoetis (ZTS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Allergan investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Athabasca Oil (ATH), Micron Technology (MU), Aegean Marine Petroleum Network (ANW), NIC (EGOV), United Rentals (URI) and Transocean (RIG).

Allergan's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (7.36%), BlackRock Inc. (6.04%), BlackRock Inc. (6.04%), Longview Partners Guernsey LTD (2.13%), Northern Trust Corp (1.21%) and Baupost Group LLC MA (1.12%). Company insiders that own Allergan stock include Brent L Saunders, Chris W Bodine, Christopher J Coughlin, Joseph H Boccuzi, Maria Teresa Hilado, Matthew M Walsh and William Meury. View Institutional Ownership Trends for Allergan.

AGN stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Janus Henderson Group PLC, King Street Capital Management L.P., Iridian Asset Management LLC CT, Baupost Group LLC MA, BlackRock Inc., BlackRock Inc. and Invesco Ltd.. View Insider Buying and Selling for Allergan.

AGN stock was purchased by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Magnetar Financial LLC, OZ Management LP, Paulson & CO. Inc., Longview Partners Guernsey LTD, Alpine Associates Management Inc., TIG Advisors LLC and TIG Advisors LLC. Company insiders that have bought Allergan stock in the last two years include Brent L Saunders, Chris W Bodine, Christopher J Coughlin, Joseph H Boccuzi, Maria Teresa Hilado and Matthew M Walsh. View Insider Buying and Selling for Allergan.

Shares of AGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of AGN stock can currently be purchased for approximately $166.47.

Allergan has a market capitalization of $54.61 billion and generates $15.79 billion in revenue each year. The company earns $-5,096,400,000.00 in net income (profit) each year or $16.69 on an earnings per share basis. Allergan employs 16,900 workers across the globe.View Additional Information About Allergan.

The official website for Allergan is http://www.allergan.com/.

Allergan's mailing address is CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2, D17 E400. The company can be reached via phone at 862-261-7000 or via email at [email protected]